Psychedelics Small Pharma gets approval for upcoming injectable DMT trial on humans New phase I study will be held at MAC Clinical Research in Manchester, England next year Rowan DunneOctober 31, 2022
Medical and Pharmaceutical The Mugglehead technology roundup: medical tech and biotechnology edition Here are five biotechnology and medical tech companies pooling their resources to make our lives easier. Joseph MortonOctober 14, 2022
Medical and Pharmaceutical Immunic secures private funding for clinical stage studies Immunic is a biopharmaceutical company that engages in clinical-stage studies involving a pipeline of oral immunology therapies Joseph MortonOctober 11, 2022
Sleep Not sleeping enough has negative impacts on immune function: NIH Researchers studied how sleep disruptions in humans and mice increased levels of immune stem cell production and circulation in bone marrow. Joseph MortonSeptember 21, 2022
Canada ATMA receives Health Canada approval for new psilocybin trial Study will evaluate psilocybin efficacy in healthcare workers with mental health challenges related to pandemic Rowan DunneSeptember 15, 2022
International PharmAla Biotech to provide University of Sydney with LaNeo MDMA for clinical studies Organization to supply GMP product for second major clinical trial down under this month Rowan DunneAugust 31, 2022
Psychedelics MindMed announces initial patient dosing in MM-120 study Biopharmaceutical company administers optimized form of LSD in Phase 2b dose-optimization trial Rowan DunneAugust 25, 2022
International Mind Medicine Australia receives AUD$1M grant for psychedelic research New fund will support studies on psychedelic-assisted therapies for the treatment of mental health conditions Rowan DunneAugust 23, 2022
Cannabis Tilray receives approval for CBD oral solution in Australia and New Zealand Flagship product from company's medical cannabis division now set for clinical trial use Rowan DunneAugust 23, 2022
Research Lobe Sciences partners with iNGENū for new clinical trials in Australia Canadian biopharmaceutical company will receive government tax incentive for studies down under Rowan DunneAugust 12, 2022